BACKGROUND: Although CD4 cell count monitoring is used to decide when to start antiretroviral therapy in patients with HIV-1 infection, there are no evidence-based recommendations regarding its optimal frequency. It is common practice to monitor every 3 to 6 months, often coupled with viral load monitoring. We developed rules to guide frequency of CD4 cell count monitoring in HIV infection before starting antiretroviral therapy, which we validated retrospectively in patients from the Swiss HIV Cohort Study. METHODOLOGY/PRINCIPAL FINDINGS: We built up two prediction rules ("Snap-shot rule" for a single sample and "Track-shot rule" for multiple determinations) based on a systematic review of published longitudinal analyses of CD4 cell count t...
Background: Most clinical guidelines recommend that AIDS-free, HIV-infected persons with CD4 cell co...
BACKGROUND: Most clinical guidelines recommend that AIDS-free, HIV-infected persons with CD4 cell co...
International audienceBACKGROUND: Most clinical guidelines recommend that AIDS-free, HIV-infected pe...
Background: Although CD4 cell count monitoring is used to decide when to start antiretroviral therap...
Background Although CD4 cell count monitoring is used to decide when to start antiretroviral ther...
Background: Although CD4 cell count monitoring is used to decide when to start antiretroviral therap...
BackgroundClinical guidelines vary with respect to the optimal monitoring frequency of HIV-positive ...
BACKGROUND: Current treatment guidelines for HIV infection recommend routine CD4 lymphocyte (CD4) co...
Purpose: CD4 cell-count has been regarded as the key surrogate marker for prognostic staging and the...
The benefits of immunologic and virologic monitoring for the management of HIV-positive individuals ...
BACKGROUND: Viral load monitoring is not available for the vast majority of patients receiving antir...
Objective: To illustrate an approach to compare CD4 cell count and HIV-RNA monitoring strategies in ...
Altres ajuts: This research was supported by NIH grant R01 AI073127; by NIH grant T32 AI007433 from ...
OBJECTIVE To illustrate an approach to compare CD4 cell count and HIV-RNA monitoring strategies i...
Background: Global programs of anti-HIV treatment depend on sustained laboratory capacity to assess ...
Background: Most clinical guidelines recommend that AIDS-free, HIV-infected persons with CD4 cell co...
BACKGROUND: Most clinical guidelines recommend that AIDS-free, HIV-infected persons with CD4 cell co...
International audienceBACKGROUND: Most clinical guidelines recommend that AIDS-free, HIV-infected pe...
Background: Although CD4 cell count monitoring is used to decide when to start antiretroviral therap...
Background Although CD4 cell count monitoring is used to decide when to start antiretroviral ther...
Background: Although CD4 cell count monitoring is used to decide when to start antiretroviral therap...
BackgroundClinical guidelines vary with respect to the optimal monitoring frequency of HIV-positive ...
BACKGROUND: Current treatment guidelines for HIV infection recommend routine CD4 lymphocyte (CD4) co...
Purpose: CD4 cell-count has been regarded as the key surrogate marker for prognostic staging and the...
The benefits of immunologic and virologic monitoring for the management of HIV-positive individuals ...
BACKGROUND: Viral load monitoring is not available for the vast majority of patients receiving antir...
Objective: To illustrate an approach to compare CD4 cell count and HIV-RNA monitoring strategies in ...
Altres ajuts: This research was supported by NIH grant R01 AI073127; by NIH grant T32 AI007433 from ...
OBJECTIVE To illustrate an approach to compare CD4 cell count and HIV-RNA monitoring strategies i...
Background: Global programs of anti-HIV treatment depend on sustained laboratory capacity to assess ...
Background: Most clinical guidelines recommend that AIDS-free, HIV-infected persons with CD4 cell co...
BACKGROUND: Most clinical guidelines recommend that AIDS-free, HIV-infected persons with CD4 cell co...
International audienceBACKGROUND: Most clinical guidelines recommend that AIDS-free, HIV-infected pe...